AlphaCentric Advisors’s Travere Therapeutics TVTX Stock Holding History

AlphaCentric Advisors’s Portfolio TVTX Stock Details TVTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$442K	Buy
2022 Q4	$392K	Buy
2021 Q3	–	Sell
2021 Q2	$897K	Buy